Announcement on Voluntary Disclosure of Inclusion of Gecacitinib Hydrochloride Tablets in the 2025 National Medical Insurance Drug Catalog
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference: View Attachment
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference: View Attachment